FDA Avandia Panel: A Twitter-Based Review

An FDA advisory panel is currently meeting to analyst a re-analysis of a clinical trial of the GlaxoSmithKline drug Avandia. For a summary of why this is important, read my piece from last night. This is a summary of what happened, culled from my tweets and those of others. #FDA's Parks says RECORD like verb, such as "Remember to recórd the show, rather than noun: I'll keep a récord of that request #Avandia $GSK
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news